RT Journal Article SR Electronic T1 Mobility patterns, activity locations, and tuberculosis in Nairobi, Kenya JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2024.09.12.24313589 DO 10.1101/2024.09.12.24313589 A1 Tram, Khai Hoan A1 Ong’ang’o, Jane A1 Kiplimo, Richard A1 Hawn, Thomas R. A1 Nduba, Videlis A1 Horne, David J. A1 Ross, Jennifer M. YR 2024 UL http://medrxiv.org/content/early/2024/09/13/2024.09.12.24313589.abstract AB Background Annually, over 3 million people develop TB but are not diagnosed and treated. We aimed to characterize the mobility patterns and activity locations of people with TB in an urban, high-burden setting to inform future active case finding (ACF) efforts.Methods We conducted a population-based TB prevalence survey in Nairobi, Kenya, in 2022. Participants aged ≥15 years with TB symptoms or a suggestive chest x-ray submitted sputum for Xpert Ultra and culture. We collected data on individual activity locations and mobility and evaluated their association with the risk of pulmonary TB.Results The prevalence survey enrolled 6369 participants across nine clusters. There were significant differences in mobility patterns and activity locations between sexes and age groups. Mobility factors were not significantly associated with TB. In the adjusted analysis, age group 45–54 (OR 2.45), male sex (OR 2.95), and use of a social activity location (OR 1.96) were significantly associated with a higher risk of TB.Conclusions We did not find a significant association between mobility patterns and TB but found a positive association between reported ‘social’ activity locations and TB. Identification of ‘social’ activity locations, particularly bars, provides important insight into possible venues for spatially-targeted ACF activities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number 5T32AI007044 [training grant to KHT] and 5R01AI150815 [DJH/TRH/VN/JR]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Boards of KEMRI (KEMRI/SERU/3988) and the University of Washington (UW STUDY00009209) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.